Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp. is a blank-check company incorporated in 2024 and headquartered in Fort Lauderdale, Florida. The company has not commenced significant operations and currently has no established business lines or revenue streams. As a Special Purpose Acquisition Company (SPAC), its stated purpose is to identify and execute a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more operating businesses.

The company trades on the Nasdaq under the ticker DMAAR. Details regarding potential target industries, investment criteria, or management experience are not disclosed in the available information. As a newly formed acquisition vehicle, the company has minimal operational scale, with no disclosed employees or geographic footprint beyond its registered headquarters location.